Indias First Urinary Incontinence Drug Launched
In India, 1 in 3 women above the age of 50 suffers from urinary incontinence impacting their quality of life. Patients suffering from
problems suffer from urgency to empty the bladder with increased daytime frequency.
Symptoms can affect psychological, social, occupational, domestic, and sexual aspects of life. Its prevalence increases with age, and due to a lack of awareness, only a small percentage are diagnosed and receive treatment.
Advertisement
Fesobig being the world’s first bioequivalent generic version of fesoterodine fumarate, it is recommended as the safest, novel first-line drug option by various international treatment guidelines for the treatment of overactive bladder (OAB) and urinary incontinence (UI).
Besides helping recover from overactive bladder (OAB), researchers are certain that Fesobig will endow patients with a much more confident way of life by eliminating the social and psychological discomfort associated with the condition. The company has ensured that the drug is priced affordably so that it can benefit a vast majority of patients.
Source: Medindia
Source link
#Indias #Urinary #Incontinence #Drug #Launched